Corporate Governance15 May 2026, 02:49 pm
Solara Adopts Board Evaluation Policy, Amends Whistle Blower Policy
AI Summary
Solara Active Pharma Sciences Ltd. has announced the approval and adoption of a Board Evaluation Policy and amendments to its Whistle Blower Policy. These changes are in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The updated policies are available on the company's website.
Key Highlights
- Solara adopts Board Evaluation Policy as per SEBI regulations.
- Whistle Blower Policy amended to align with applicable requirements.
- Policies are available on the company's website for investor access.
- Board approval occurred on May 15, 2026.
Price Impact
More from SOLARA